SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001537055-18-000004
Filing Date
2018-02-14
Accepted
2018-02-14 12:07:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 orexye17.txt SC 13G/A 29457
  Complete submission text file 0001537055-18-000004.txt   30930
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Subject) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-83422 | Film No.: 18609575
SIC: 2834 Pharmaceutical Preparations

Mailing Address 545 FIFTH AVE SUITE 1108 NEW YORK NY 10017
Business Address 545 FIFTH AVE SUITE 1108 NEW YORK NY 10017 212-425-9700
Telemetry Investments, L.L.C. (Filed by) CIK: 0001537055 (see all company filings)

IRS No.: 134081603
Type: SC 13G/A